Watanabe Hiromitsu, Watanabe Kyohei, Matsushita Yuto, Tamura Keita, Motoyama Daisuke, Otsuka Atsushi, Inamoto Teruo, Miyake Hideaki
Department of Urology Hamamatsu University School of Medicine Hamamatsu Japan.
Department of Developed Studies for Advanced Robotic Surgery Hamamatsu University School of Medicine Hamamatsu Japan.
IJU Case Rep. 2025 Mar 12;8(3):244-248. doi: 10.1002/iju5.70016. eCollection 2025 May.
Robot-assisted radical cystectomy (RARC) is becoming the standard treatment for bladder cancer patients. While this surgery using da Vinci has been widely reported, this report describes the initial experience of RARC with intracorporeal neobladder using the hinotori surgical robot system.
The patient was a 73-year-old man with muscle-invasive bladder cancer who underwent neoadjuvant chemotherapy followed by RARC with intracorporeal neobladder using hinotori. Surgery was successfully performed with a total operative time of 430 min, time using the robotic system of 375 min, and no intraoperative complications or need for blood transfusion. Postoperative recovery was favorable, with the patient discharged on day 12, and satisfactory continence was achieved.
This is the initial case report of RARC with intracorporeal neobladder using hinotori, providing a potentially comparable alternative to conventional surgical systems for RARC.
机器人辅助根治性膀胱切除术（RARC）正成为膀胱癌患者的标准治疗方法。虽然使用达芬奇机器人进行的这种手术已有广泛报道，但本报告描述了使用火鸟手术机器人系统进行体内新膀胱RARC的初步经验。
该患者为一名73岁的肌肉浸润性膀胱癌男性，接受了新辅助化疗，随后使用火鸟机器人进行了体内新膀胱RARC。手术成功完成，总手术时间为430分钟，使用机器人系统的时间为375分钟，术中无并发症且无需输血。术后恢复良好，患者于第12天出院，实现了满意的控尿。
这是使用火鸟机器人进行体内新膀胱RARC的首例病例报告，为RARC提供了一种可能与传统手术系统相当的替代方案。
